✦ LIBER ✦

Adoptive immunotherapy for unresectable or recurrent pancreatic cancer, using lymphokine-activated killer cells or cytotoxic T cells

✍ Scribed by Oka, Masaaki ;Suzuki, Michinari ;Hazama, Shoichi ;Suzuki, Takashi

Publisher: Springer
Year: 1994
Tongue: English
Weight: 513 KB
Volume: 1
Category: Article
ISSN: 0944-1166
DOI: 10.1007/bf01222242

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive immunotherapy for recurrent gli

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2

✍ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i

The requirements for successful immunoth

The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells

✍ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the